Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMCT
2926
Creative Media & Community Trust
CMCT
$10.1M
| $1.01M | ﹤0.01% |
5
+2
| +67% | +$536K |
|
2927
Transcat
TRNS
$778M
| $1.01M | ﹤0.01% |
17,898
| – | – |
|
|
GOLD
2928
Gold.com Inc
GOLD
$1.22B
| $1.01M | ﹤0.01% |
43,466
-30,518
| -41% | -$681K |
|
2929
Gaia
GAIA
$46.8M
| $1.01M | ﹤0.01% |
91,478
+59,651
| +187% | +$677K |
|
2930
Entravision Communication
EVC
$1.07B
| $1M | ﹤0.01% |
149,796
+1,281
| +0.9% | +$5.79K |
|
2931
Farmers National Banc Corp
FMNB
$941M
| $1M | ﹤0.01% |
64,438
+184
| +0.3% | +$3.09K |
|
|
ITIC
2932
Investors Title Co
ITIC
$548M
| $996K | ﹤0.01% |
5,702
+281
| +5% | +$48.9K |
|
2933
Rio Tinto
RIO
$158B
| $996K | ﹤0.01% |
11,878
-1,350
| -10% | -$116K |
|
2934
Kodak
KODK
$819M
| $993K | ﹤0.01% |
119,294
+61,472
| +106% | +$482K |
|
2935
Quantum Corp
QMCO
$443M
| $991K | ﹤0.01% |
7,185
+1,822
| +34% | +$295K |
|
2936
Neuronetics
STIM
$137M
| $991K | ﹤0.01% |
+61,831
| New | +$854K |
|
|
AWH
2937
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $989K | ﹤0.01% |
11,728
-1,834
| -14% | -$158K |
|
2938
Citius Pharmaceuticals
CTXR
$17.4M
| $988K | ﹤0.01% |
11,351
+9,630
| +560% | +$579K |
|
2939
Blue Bird Corp
BLBD
$2.36B
| $980K | ﹤0.01% |
39,405
-91
| -0.2% | -$2.39K |
|
2940
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $980K | ﹤0.01% |
70,296
+4,850
| +7% | +$73.7K |
|
2941
MeiraGTx Holdings
MGTX
$1.11B
| $979K | ﹤0.01% |
63,112
+12,206
| +24% | +$174K |
|
|
AKYA
2942
DELISTED
Akoya BioSciences
AKYA
| $978K | ﹤0.01% |
+50,522
| New | +$1.04M |
|
2943
Daily Journal
DJCO
$819M
| $967K | ﹤0.01% |
2,854
-26
| -0.9% | -$8.35K |
|
|
ICAD
2944
DELISTED
iCAD Inc
ICAD
| $966K | ﹤0.01% |
55,785
+3,087
| +6% | +$54.1K |
|
2945
Radiant Logistics
RLGT
$388M
| $962K | ﹤0.01% |
138,810
+35,864
| +35% | +$260K |
|
|
AMNB
2946
DELISTED
American National Bankshares Inc
AMNB
| $953K | ﹤0.01% |
30,633
+3,662
| +14% | +$123K |
|
2947
Citizens & Northern Corp
CZNC
$456M
| $952K | ﹤0.01% |
38,845
+3,752
| +11% | +$92.2K |
|
2948
Rocky Brands
RCKY
$366M
| $952K | ﹤0.01% |
17,113
-26,908
| -61% | -$1.51M |
|
|
VIRX
2949
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $951K | ﹤0.01% |
+83,792
| New | +$841K |
|
2950
Corbus Pharmaceuticals
CRBP
$168M
| $943K | ﹤0.01% |
17,167
-79
| -0.5% | -$4.38K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.